Extracorporeal Shock Wave Lithotripsy success rate for upper and lower ureteric stones in Azadi-teaching (Dohuk) hospital in Kurdistan Region-Iraq

2017 ◽  
Vol 13 (2) ◽  
pp. 48-55
Author(s):  
Kamiran J Sadeeq ◽  
Author(s):  
Fatma M. Elaiashy ◽  
Mohamed M. Abu Elyazd ◽  
Ahmed A. Eldaba ◽  
Tarek A. Gameel

Background: Thoracic paravertebral block (TPVB) produces ipsilateral somatic and sympathetic nerve blockade in multiple contiguous dermatomes both above and below the site of injection.  The Aim of This Study: was to compare the effectiveness of ultrasound-guided TPVB versus intravenous (IV) sedative analgesic using midazolam / fentanyl in patients undergoing extracorporeal shock wave lithotripsy (ESWL) procedure. Patients and Methods: This prospective, randomized study was carried out on sixty patients aged 20-60 years, with radio-opaque renal stone not more than1.5cm. TPVB group (30 patients) received ipsilateral ultrasound-guided TPVB at the level T9-T10 using bupivacaine 0.25% (20 mL) about 30 minutes before the ESWL. Midazolam/fentanyl group (30 patients) received sedatives analgesic drugs using IV midazolam (0.05 mg / kg) and fentanyl (1 µg/kg) about 5 min before the ESWL. The VAS score during and 30 min post procedure, total dose of rescue analgesic consumption during ESWL procedure, the success rate of ESWL, the time needed to stone clearance, patient and operator satisfaction scores were recorded. Result: During and after ESWL procedure, the VAS scores were significantly higher in midazolam/fentanyl group than TPVB group (P < 0.05). The number of patients required rescue analgesic during ESWL was significantly higher in midazolam/fentanyl group compared to TPVB group (P < 0.05).The success rate of ESWL was insignificantly different between both groups (P > 0.05). The time needed to stone clearance was significantly shorter in TPVB group compared to midazolam/fentanyl group (P < 0.05). Conclusions: Ultrasound-guided TPVB provided more effective analgesia with reduced number of ESWL sessions and shorter time to renal stone clearance than IV midazolam/fentanyl.


2018 ◽  
Vol 1 (2) ◽  
pp. 102-104
Author(s):  
Dhruba Bahadur Adhikari ◽  
David Shrestha ◽  
Anup Shrestha

Introduction: The aim of the study was to observe the success rate of extracorporeal shock wave lithotripsy (ESWL) in the management of upper urinary tract stones. Materials and Methods: This retroprospective study was conducted in Pokhara Kidney stone Centre, Pokhara, Kaski, Nepal from January 2017 to January 2018. Seventy nine patients were selected in this study with upper urinary tract stone, size less than 20 mm. Results: Seventy four (93.67%) patients were successfully treated in initial use of shock wave and 5 (6.32%) patients required repetition. Conclusion: Overall satisfactory success rate was observed using ESWL for the upper urinary tract stone. Careful selection of patient, stone size and Hounsfield unit (HU) is advisable.


2013 ◽  
Vol 28 (4) ◽  
pp. 255-259 ◽  
Author(s):  
Mohammed S. Al-Marhoon ◽  
Omar Shareef ◽  
Ismail S. Al-Habsi ◽  
Ataalrahman S. Al Balushi ◽  
Josephkunju Mathew ◽  
...  

2006 ◽  
Vol 34 (3) ◽  
pp. 215-221 ◽  
Author(s):  
Mustafa Ozgur Tan ◽  
Mustafa Kirac ◽  
Metin Onaran ◽  
Ustunol Karaoglan ◽  
Nuri Deniz ◽  
...  

2011 ◽  
Vol 4 (6) ◽  
pp. 243-247 ◽  
Author(s):  
R. Farrands ◽  
B.W. Turney ◽  
P.V.S. Kumar

Objective: To evaluate the success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of ureteric calculi and determine the factors which influence outcome. Patients and methods: A retrospective audit of patients with a single ureteric stone receiving ESWL was performed. Success was defined as complete stone clearance on post-treatment imaging. Patient demographics and stone characteristics were correlated to ESWL outcome. Results: 108 patients met the inclusion criteria for this study. The mean age of the patients was 52.5 years (range 24–89 years). 80% (86/108) of patients were male. Stone sizes varied from 4 to 19 mm (mean 7.92 mm). The overall ESWL success rate for ureteric stones was 79%. Treatment was more effective for smaller ( p = 0.003) and more located stones ( p = 0.035). Stone size correlated with number of treatments required ( p =0.005). A JJ stent in situ at the time of ESWL reduced the success rate ( p = 0.002). Conclusions: Stone size, site in the ureter, and the presence of a JJ stent were predictors of ESWL success. Our study from a District General Hospital in the UK demonstrates that ESWL may be used with high efficacy to treat ureteric stones.


2020 ◽  
Vol 22 (2) ◽  
pp. 141-150
Author(s):  
Md Abdur Rakib ◽  
Md Shahidul Islam ◽  
SM Shameem Waheed

Background: Renal stone disease is a common disorder with a prevalence ranging from 4-15% in different parts of the world. Modalities of kidney stone management includes drug therapy, extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), Retrograde intrarenal surgery ureteroscopy (RIRS) and open surgery. ESWL is an acceptable technique and widely used because it is a non-invasive treatment and does not require anesthesia and usually done on an outpatient basis. Generally, ESWL is the treatment of choice for kidney stones <1 cm. However, not all ESWL treatments are successful. The success rate has been reported to be between 50%-87%, depending on various factors. This study was conducted in order to evaluate thefactors affecting renal stones treatment by extracorporeal shock wave lithotripsy (ESWL).On the basis of different variables andfactors affecting the renal stones treatment by ESWL was evaluated. Objectives: To evaluate the factors affecting the outcome of Extracorporeal Shock Wave Lithotripsy (ESWL) in the treatment of renal stone in adults.To assess the success and failure rate by using ESWL for treatment of renal stone, to determine the effects of stone related factors to correlate the success rate with characteristics of the patients condition of the urinary tract and stone features; to observe the patient groups most likely to benefit from or fail an initial intervention with ESWL and to evaluate the post ESWL complications. Materials and methods: This is a prospective observational and analytical, hospital based study. Total 500 patients with single or multiple radio-opaque renal stones were treated with ESWL monotherapy using Siemens MODULARIS Variostarlithotriptor. This study was carried out inthe Department of Urology, Combined Military Hospital, Dhaka for a period of two years between 01 July 2015 to 31 July 2017. The results of treatment were evaluated after 3 months of follow-up. Treatment success was defined as complete clearance of the stones or presence of clinically insignificant residual fragments (<3mm). The results of treatment were correlated with the patient characteristics (age, sex, body mass index) and stone features (size, site, number & radio density). Results: At 3-months follow-up, the overall success rate is 87.6%. Among them, repeated ESWL sessions were required in 266 patients (53.2%). Post-ESWL complications were recorded in 62 patients (12.4%). Using the chi-square test, only four factors have a significant impact on the success rate, namely stone site, size (the largest diameter of the stone), stone number, BMI (body mass index) of the patient. The success rate is highest for stones located in the upper calyx (136/136; 100%) and lowest for those located in lower calyx 104/78; 75%) (p=0.001). Stone with a largest diameter of <10mm are associated with a success rate of 93.6% (307/328), compared to 76.2% (131/172) for those with a diameter of >10mm (p=0.001). The success rate was also higher for single stone (396/437; 90.6%) than multiple stones (42/63; 66.7%) (p=.001). Patients with lower BMI (<24) have a better success than higher BMI (>25) (p=.001). Other factors including age, sex and stone radio density compared to ipsilateral 12th rib have no significant impact on the success rate. Conclusion: The success rate of ESWL for the treatment of renal stones can be predicted by stone size, location, number, and patients BMI. Bangladesh Journal of Urology, Vol. 22, No. 2, July 2019 p.141-150


2004 ◽  
Vol 38 (2) ◽  
pp. 161-167 ◽  
Author(s):  
Mohamed Abdel‐Khalek ◽  
Khaled Z. Sheir ◽  
Alaa A. Mokhtar ◽  
Ibrahiem Eraky ◽  
Mahmoud Kenawy ◽  
...  

Urology ◽  
2005 ◽  
Vol 66 (1) ◽  
pp. 24-28 ◽  
Author(s):  
Giovanni Luca Gravina ◽  
Alessia Mariagrazia Costa ◽  
Piero Ronchi ◽  
Giuseppe Paradiso Galatioto ◽  
Adriano Angelucci ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document